#tamiflu

[alexishectorr]

Tamiflu and Relenza review questions effectiveness against flu

Tamiflu (oseltamivir) and Relenza (zanamivir) are classes of drugs known as neuraminidase inhibitors. Both drugs are thought to prevent and reduce symptoms of flu by stopping the influenza virus from spreading inside the body.

At present, Tamiflu is used to combat flu in patients 2 weeks of age and older whose symptoms have not lasted longer than 2 days. It can be used to prevent flu in patients aged 1 year and older. Relenza is used to tackle flu in patients aged 7 years and older and can be used for flu prevention in those aged 5 years and older.

According to the researchers involved in this latest review, including Dr. Carl Heneghan of the University of Oxford in the UK and Dr. Peter Doshi of the University of Maryland School of Pharmacy in the US, both drugs are stockpiled for use against seasonal and pandemic influenza. For example, the US has spent over $1.3 billion on reserves of influenza antivirals.

This stockpiling has been based on international and national recommendations from bodies such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC). But what are their recommendations based on?

[orbesargentina]

El Tamiflu, la droga antigripal, cambió su personalidad y lo llevó a suicidarse https://bit.ly/3SefGRY

[madaqueue]

whoever invented tamiflu deserves their ass eaten

[eiluned]

*stands up, clears throat, does a little tap dance*

Why am I so fucking tired??

[drathanasius]

[measureyourlifeincake]

In case anyone was curious, Yentl opened last night and it went really well!

Unfortunately, I seem to have caught the flu :(

[thahxa]

btw if yall are not paying attention to the bird flu thing id recommend doing it, allegedly (unsourced from twt) the cdc is slow-rolling tests like early covid

for various reasons i dont think this is "lock down immediately" (seems limited with not too much spread) but probably doesn't hurt to start thinking about it

[si-cucumber]

One of my favorite things about being a writer is that me and my friends never ever call my characters by their full names. Everyone has a nickname they get called instead, like you do with a pet.

[cassandraleeds]

I'm gonna see Ghost in July. :3

[damnwormholes]

this morning: cold flu cold flu cold flu cold flu cold flu cold flu cold flu

[track-five]

Good luck with your appointment, hopefully you don’t have anything major!

🩵 she said if i was in person she’d probably flu test me, but it’s not worth coming in since 1. i don’t have a cough/respiratory anything and 2. even if i did have it, a side effect of tamiflu is stomach issues which i do not need!

[evilhatefilledgirl]

influenza A is a whole different bitch than influenza B

[canyourlawnmowerdothis]

i actually feel pretty fine right now so im trying to get shit done. maybe ill even wash my face

[socctime]

everything is terrible

[bartruto]

customers talking about me still wearing my mask but the person behind them is coughing up a lung…

[writerblogs]

Global Tamiflu (oseltamivir phosphate) Market Is Estimated To Witness High Growth Owing To Rising Awareness about Influenza Outbreaks

The global Tamiflu (oseltamivir phosphate) market is estimated to be valued at US$ 889.2 million in 2022 and is expected to exhibit a CAGR of 1.2% over the forecast period of 2022-2030, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: Tamiflu (oseltamivir phosphate) is an antiviral medication primarily prescribed for the treatment and prevention of influenza (flu) in adults and children aged 1 year and older. It is effective against both influenza A and B viruses. Tamiflu works by inhibiting the growth of the virus and reducing the severity and duration of flu symptoms. The need for Tamiflu arises due to the frequent outbreaks of influenza, especially during flu seasons. Influenza can lead to severe illness, hospitalization, and even death, making it crucial to manage and control its spread. Tamiflu plays a vital role in reducing the impact of influenza outbreaks by providing timely treatment and preventing further transmission. B) Market Key Trends: One key trend in the Tamiflu (Oseltamivir Phosphate) Market is the rising awareness about influenza outbreaks and the importance of early treatment. With increasing access to information and education about influenza, individuals are more likely to seek medical intervention at the earliest signs of flu symptoms. This trend has led to a higher demand for Tamiflu as people recognize the benefits of early treatment in reducing the severity and duration of the illness. For example, during the COVID-19 pandemic, there has been a heightened awareness about respiratory illnesses, including influenza. People are more cautious and proactive in seeking medical attention for flu-like symptoms, leading to increased prescription rates for Tamiflu. C) PEST Analysis: - Political: Governments worldwide are taking initiatives to control and manage influenza outbreaks by promoting vaccination programs and ensuring the availability of antiviral medications such as Tamiflu. - Economic: The Tamiflu market is driven by the economic burden caused by influenza outbreaks, including healthcare costs, productivity loss, and hospitalizations. The market is also influenced by healthcare expenditure and reimbursement policies. - Social: Increasing awareness about the severity of influenza and the importance of early treatment has contributed to the demand for Tamiflu. Public health campaigns and educational initiatives have played a significant role in shaping social attitudes towards flu prevention and management. - Technological: Advancements in influenza diagnostic tests and antiviral treatments have enhanced the effectiveness of Tamiflu. Technological innovations in drug delivery systems have also improved patient compliance and convenience. D) Key Takeaways: - The global Tamiflu market is expected to witness high growth, exhibiting a CAGR of 1.2% over the forecast period, due to increasing awareness about the importance of early treatment for influenza. - Regional analysis indicates that North America is the fastest-growing and dominating region in the Tamiflu market. The region has well-established healthcare infrastructure, high awareness levels, and a proactive approach towards managing influenza outbreaks. - Key players operating in the global Tamiflu market include F.Hoffmann-La Roche Ltd., NATCO Pharma Limited, Teva Pharmaceutical Industries Ltd., LUPIN Limited, Amneal Pharmaceuticals LLC, Zydus Cadila, Sun Pharmaceutical Industries Ltd., Alembic Pharmaceuticals Limited, Mylan N.V., and Hetero Group. In conclusion, the global Tamiflu market is poised for growth due to rising awareness about influenza outbreaks and the significance of early treatment. The market is driven by the need to control the spread of influenza and reduce its impact on public health. North America emerges as the leading region in this market, while key players continue to innovate and cater to the increasing demand for Tamiflu.